Pediatr. praxi. 2010;11(6):354-357

Immunological principles of safety vaccination in children

MUDr.Vojtěch Thon, Ph.D.
Ústav klinické imunologie a alergologie LF MU a FN u sv. Anny v Brně, Univerzitní centrum pro primární imunodeficience

The requirement of successful vaccination is safety. In past iatrogenic injuries of children after vaccination, incl. deaths were documented

in the Czech Republic because of vaccine interactions and insufficient respect to contraindications. Therefore we recommend changing

of current practice of BCG vaccination considering new immunization schedule with hexavalent vaccine. We advise to postpone BCG

vaccination until the second half of the child’s first year of life which is in accordance with the WHO and leads even to the protection

of avian mycobacteriosis. Moreover, implementation of TRECs into the newborn screening from dried blood spot would increase the

preventive approach to early immunodeficiency diagnostics.

Keywords: vaccination, BCG, BCG-osis, hexavalent vaccine, rotavirus, TREC, immunodeficiency

Published: December 9, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Thon V. Immunological principles of safety vaccination in children. Pediatr. praxi. 2010;11(6):354-357.
Download citation

References

  1. Charvát J. Život, adaptace a stress. 1. vyd. Praha: SZN, 1969.
  2. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009; 124: 1161-1178. Go to original source... Go to PubMed...
  3. Gathmann B, Grimbacher B, Beauté J, et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol. 2009; 157(Suppl. 1): 3-11. Go to original source... Go to PubMed...
  4. Thon V. Nutnost posunu BCG vakcinace - poučení z komplikací a úmrtí dětí s vrozenými imunodeficiencemi. Stud Pneumol Phthiseol. 2010; 70(1): 30-34.
  5. Bustamante J, Boisson-Dupuis S, Jouanguy E, et al. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr Opin Immunol. 2008; 20: 39-48. Go to original source... Go to PubMed...
  6. Roitt I. Imunita proti infekcii. In Roitt I. Základy imunológie. Martin: Osveta, 1981: 188-192.
  7. Křepela K, Mladá J. Problematika BCG vakcinace v České republice. Vakcinologie 2008; 2: 97-111.
  8. Thon V. Bezpečný postup očkování proti tuberkulóze. Parlament České republiky, odborný seminář Problematika očkování v ČR, 30. 3. 2010.
  9. Thon V, Litzman J, Lokaj J. Necessity of postpone BCG vaccination - Lesson from primary immunodeficiencies. Eur J Immnol. 2009; 39: S 261.
  10. Křepela K. Problematika dětské tuberkulózy a BCG vakcinace. Pediatrie po promoci 2004; 1: 55-59.
  11. Bakare N, Menschik D, Tiernan R, et al. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine 2010; 28(40): 6609-6612. Go to original source... Go to PubMed...
  12. Patel NC, Hertel PM, Estes MK, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med. 2010; 362(4): 314-319. Go to original source... Go to PubMed...
  13. Baker MW, Laessig RH, Katcher ML, et al. Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program. Public Health Rep. 2010; 125(Suppl. 2): 88-95. Go to original source... Go to PubMed...
  14. Puck JM, et al. Population-based newborn screening for severe combined immunodeficiency: Steps toward implementation. J Allergy Clin Immunol. 2007; 120: 760-768. Go to original source... Go to PubMed...
  15. Parida SK, Kaufmann SH. Novel tuberculosis vaccines on the horizon. Curr Opin Immunol. 2010; 22(3): 374-384. Go to original source... Go to PubMed...
  16. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010; 375(9731): 2110-2119. Go to original source... Go to PubMed...
  17. Finegold I. Nontuberculous mycobacterial infection in the differential diagnosis of chronic cough. Allergy Asthma Proc. 2008; 29: 343-344. Go to original source... Go to PubMed...
  18. Kubín M, Kruml J, Horák Z, et al. Pulmonary and nonpulmonary disease in humans due to avian mycobacteria. Am Rev Resp Dis. 1966; 94: 20-39. Go to PubMed...
  19. Kříž P, Slaný M, Shitaye JE, Pavlík I. Aviární mykobakteriózy u lidí - stále hrozící nebezpečí v České republice. Klin Mikrobiol Inf Lek 2010; 16(1): 10-17.
  20. Kazda J, Pavlik I, Falkinham III JO, Hruska K. The Ecology of Mycobacteria: Impact on Animal's and Human's Health. Springer, 2009. Go to original source...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.